female sexual dysfunction Los Angeles

What is a Female Viagra Medication?

Sexual dysfunction is common is a common occurrence during the lifetime for a  significant amount of women. The condition can be caused or exacerbated by various things, which can make diagnosing  and treating female sexual dysfunction more complicated (but not impossible). Recently, researchers have developed a medication that may be of some use for certain women with FSD, often referred to as female Viagra medication. It, of course, gains its nickname from Viagra, the drug used in the treatment of male erectile dysfunction.The technical name for the medication is Flibanserin, Addyi being the brand name.

Types of FSD

  • Hypoactive sexual desire disorder: Low libido
  • Sexual arousal disorder: Difficulty becoming, and staying, aroused
  • Sexual aversion disorder: Feelings of disgust, fear, or revulsion during consensual sexual intercourse
  • Orgasmic disorder: Frequent difficulty achieving orgasm
  • Dyspareunia: Painful intercourse
  • Vaginismus: Painful vaginal spasms in response to sexual intercourse

Flibanserin

Flibanserin is a medication that has been approved by the Food and Drug Administration to be used as a treatment for female sexual dysfunction. It is sold under the name Addyi, and can only be obtain with a prescription written by a licensed medical doctor (MD). More specifically, this “female Viagra” is given to women who struggle with hypoactive sexual desire disorder. This subcategory of FSD is typically experienced by premenopausal women, though there are exceptions to this statement. The drug works by altering specific brain chemicals that are involved in sexual responses. By balancing chemical levels, Flibanserin helps to regulate said responses and increase female libido.female sexual dysfunction Los Angeles

A study evaluating the efficacy of 100 milligrams of Flibanserin taken daily for a period of 24 weeks was recently conducted. The average age of the participants was 36 years old, with the median duration of hypoactive sexual desire disorder being five years, notes The Food and Drug Administration. Half of these individuals received Addyi, while the other half received a placebo treatment. Success was measured by self-reports, in which each woman rated her number of satisfying sexual encounters, as well as the distress that was felt due to low sexual desire during each of them. Rating scales ran from zero to four. The Food and Drug Administration says that of the women who were administered the true treatment, there was a 0.5 increase in sexual satisfaction and a 0.4 decrease in distress. Each dose of Flibanserin was administered at bedtime.

FSD Los Angeles Clinical Trials

Los Angeles clinical trials are a necessary portion of medical research. Without them, all of the approved drugs, therapies and other treatments could not be made available to the public. This is because clinical trials are used to assess the safety and usefulness of an experimental treatment; releasing questionable therapeutic tools for mass use would be reckless and dangerous. In the case of female Viagra for treatment of female sexual dysfunction, Flibanserin would not have been brought to the market if clinical trials have resulted in less than optimal data.

Aside from the above benefits, clinical trials can be rewarding for the people who take part in them. Subjects are recruited on a voluntary basis and must meet certain eligibility criteria to qualify. By choosing to join a Los Angeles clinical trial, women with FSD actively put themselves in an environment in which knowledgeable professionals will be present. This means that they will receive the best care, and will be able to get accurate answers to any questions they may have. Also, there is the possibility that the treatment being tested will be viable, and those in the study will be among the first few people to have access to it. Lastly, clinical trials are often paid, meaning that women will likely receive enough compensation to cover transportation costs, missed work days, and other necessary expenses.
Throughout a woman’s lifetime, there is a moderate possibility that she will be faced with some form of female sexual dysfunction disorder. Researchers have begun to develop medications that may be helpful for some of these women. Flibanserin, commonly referred to as female Viagra, is a new medication that has been approved for treating hypoactive sexual desire disorder. It has been shown to increase female libido, consequently affecting sexual pleasure in a positive manner, and lessening emotional distress associated with the condition. For women who are struggling with FSD and believe that Flibanserin may benefit them, they should contact a doctor to inquire about whether or not it is best option for them.

To learn more about clinical studies Los Angeles for female sexual dysfunction, contact the Pacific Institute of Medical Research, which is an independent clinical research site specializing in psychiatry since 1982. Visit us online or call us at (310) 208-7144.

Leave a Reply